R. Bayly

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

D. Dearnaley, R. A’Hern, V. Lewington, 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

Nature of thyrotropin displacement activity in subacute thyroiditis.

J. Wall, R. Bayly, C. Strakosch, 1982, The Journal of clinical endocrinology and metabolism.

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy.

A. McEwan, V. Lewington, P. Macleod, 1991, The British journal of radiology.

DEMONSTRATION OF A CIRCULATING AUTOANTIBODY AGAINST A SOLUBLE EYE-MUSCLE ANTIGEN IN GRAVES' OPHTHALMOPATHY

H. Sikorska, J. Wall, R. Bayly, 1982, The Lancet.

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone.

A. McEwan, A. Porter, V. Lewington, 1991, European journal of cancer.

Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy.

H. Sikorska, J. Wall, R. Bayly, 1984, The Journal of clinical endocrinology and metabolism.

Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase in relatives from two families with a high prevalence of Graves' hyperthyroidism: A ten-year follow-up study

J. Wall, M. Wellby, R. Bayly, 2004, Journal of Clinical Immunology.